Dawnrays Pharmaceutical Holdings Ltd. (HK:2348) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Dawnrays Pharmaceutical Holdings Ltd. has announced the grant of 16 million share options to 17 eligible employees, including the CEO, under their 2023 Share Option Scheme. The options are exercisable over six years with a staggered vesting schedule, starting at HK$1.25 per share. This incentive aims to motivate employees’ performance and commitment to the company’s success.
For further insights into HK:2348 stock, check out TipRanks’ Stock Analysis page.